Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

  • Unicycive Therapeutics (NASDAQ:UNCY) shares rose 27.9% to $1.65 during Thursday's after-market session. The company's market cap stands at $24.7 million.
  • Clearside Biomedical (NASDAQ:CLSD) stock increased by 15.06% to $1.68. The company's market cap stands at $100.2 million.
  • Cingulate (NASDAQ:CING) shares increased by 12.49% to $1.35. The company's market cap stands at $15.2 million.
  • Aerie Pharmaceuticals (NASDAQ:AERI) stock moved upwards by 8.47% to $6.4. The company's market cap stands at $303.0 million. As per the news, the Q4 earnings report came out today.
  • Silk Road Medical (NASDAQ:SILK) stock rose 7.69% to $34.0. The company's market cap stands at $1.1 billion. As per the news, the Q4 earnings report came out today.
  • Avalon Globocare (NASDAQ:AVCO) stock moved upwards by 5.83% to $0.78. The market value of their outstanding shares is at $68.9 million.

Losers

  • Pulmatrix (NASDAQ:PULM) stock fell 15.7% to $0.32 during Thursday's after-market session. Pulmatrix's trading volume hit 423.4K shares by close, accounting for 40.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $17.7 million.
  • Dermata Therapeutics (NASDAQ:DRMA) shares decreased by 11.67% to $1.06. The market value of their outstanding shares is at $8.8 million.
  • Virpax Pharmaceuticals (NASDAQ:VRPX) stock fell 11.22% to $1.82. The market value of their outstanding shares is at $21.3 million.
  • OPKO Health (NASDAQ:OPK) shares declined by 8.98% to $2.94. At the close, OPKO Health's trading volume reached 104.9K shares. This is 1.9% of its average volume over the last 100 days. The company's market cap stands at $2.0 billion. As per the news, the Q4 earnings report came out today.
  • Tabula Rasa HealthCare (NASDAQ:TRHC) stock decreased by 7.71% to $4.31. The company's market cap stands at $110.8 million. As per the news, the Q4 earnings report came out today.
  • Histogen (NASDAQ:HSTO) stock declined by 6.43% to $0.22. The market value of their outstanding shares is at $10.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.